Completed PHASE2 INTERVENTIONAL 5-arm NCT00852995

Dose Finding Study of HP802-247 in Venous Leg Ulcers

A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers

Sponsor: Healthpoint

Conditions Venous Leg Ulcer Venous Stasis Ulcers

Interventions HP802-247 Placebo (Vehicle)

Updated 6 times since 2017 Last updated: Sep 13, 2016 Started: Feb 28, 2009 Primary completion: Apr 30, 2011 Completion: Jul 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00852995, this PHASE2 trial focuses on Venous Leg Ulcer and Venous Stasis Ulcers and remains completed. Sponsored by Healthpoint, it has been updated 6 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Feb 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Healthpoint

Data source: Healthpoint

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Arlington, United States , Baltimore, United States , Bellevue, United States , Boston, United States , Castro Valley, United States , Chapel Hill, United States , Chicago, United States , Dallas, United States , Emerson, United States , Encinitas, United States and 20 more locations